Proxy Votes Now

Home › Funds › Putnam › Putnam Global Health Care Fund

Putnam Global Health Care Fund (PCHSX) proxy voting record 2025-2026

Fund family: Putnam · Filed by PUTNAM GLOBAL HEALTH CARE FUND (CIK 357295) · SEC series S000005666

Share classes and tickers: PCHSX (C000015517), PHSBX (C000015516), PHSRX (C000015519), PHSTX (C000015515), PHSYX (C000015520)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 431 with, 18 against, 8 abstentions (not counted as with management); 5 items carried no recommendation. Shareholder proposals: 1 FOR, 17 AGAINST, 5 abstained, by the filing’s own vote-source field.

Compared with Putnam as a whole

The same two figures as Putnam’s manager page (91,627 ballot items across 55 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsPutnamItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)95.7%41492.4%79,249
Backed environmental and social shareholder proposals at US companiesn/a70.7%1,753

Where this fund voted differently from most Putnam funds

Each ballot item this fund voted is set against the votes of the other Putnam funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Putnam funds on 1 item (0.2% of the 415 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Putnam fundsMgmtResult
Gilead Sciences, Inc.2026-04-30Shareholder To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting.AgainstFOR — 5 of 9 Putnam fundsForNot approved, 27.1% support

Download all 1 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 71.1% of this fund’s 457 such votes could be given a sector; the other 132 (28.9%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care295175.8%
Consumer Staples1715.9%
Industrials1300.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections3050
Audit-related340
Compensation340
Corporate Governance3211
Say-on-Pay270
Capital Structure200
Other Social Issues64
Environment or Climate33
Other10
Shareholder Rights and Defenses10

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Eli Lilly and CompanyMay 4, 2026$246M102
Johnson & JohnsonApril 23, 2026$161M151
AbbVie Inc.May 8, 2026$120M81
UnitedHealth Group IncorporatedJune 1, 2026$110M121
Thermo Fisher Scientific Inc.May 20, 2026$93M130
McKesson CorporationJuly 30, 2025$88M140
Merck & Co., Inc.May 26, 2026$87M183
Intuitive Surgical, Inc.April 30, 2026$54M130

Notable votes against management

MeetingCompanyProposalFundMgmt
May 4, 2026Eli Lilly and CompanyShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalAgainstFor
May 4, 2026Eli Lilly and CompanyShareholder proposal to prepare an annual lobbying report. Shareholder proposalAgainstFor
April 23, 2026Johnson & JohnsonIndependent Board Chair Shareholder proposalAgainstFor
May 8, 2026AbbVie Inc.Stockholder Proposal - to Adopt a Policy to Require an Independent Chair Shareholder proposalForAgainst
June 1, 2026UnitedHealth Group IncorporatedIf properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposalAgainstFor
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
May 13, 2026Vertex Pharmaceuticals IncorporatedShareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder proposalAgainstFor
May 14, 2026CVS Health CorporationStockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposalAgainstFor
May 5, 2026Bristol-Myers Squibb CompanyShareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director Shareholder proposalAgainstFor

Funds that vote the same way

These funds reported the same votes as Putnam Global Health Care Fund in the latest season, so they share this page:

Search this fund’s votes by company

463 ballot items at 37 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Putnam Global Health Care Fund (PCHSX) voted at 37 shareholder meetings of 34 companies, on 463 ballot items in all. Where management made a recommendation, the fund followed it on 94.3% of the items and voted against it 18 times. Its most frequent area of disagreement was corporate governance (11 of its votes against management). It voted on 23 shareholder proposals. It voted FOR the board's own proposals more often than Putnam's funds as a whole (95.7% against 92.4%). It voted differently from most Putnam funds on 1 item.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Putnam’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.